We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




SIDS Linked to Brain Defect

By HospiMedica staff writers
Posted on 30 Nov 2006
A new study has found that babies at risk of sudden infant death syndrome (SIDS) are born with abnormalities in the brainstem.

Researchers from Children's Hospital Boston (MA, USA) and Harvard Medical School (Boston, MA, USA) examined frozen medullae from 31 infants who died from SIDS and 10 controls who died from other causes, obtained from the San Diego (CA, USA) medical examiner's office between 1997-2005. More...
The researchers found that medullary serotonin-using neurons exhibited an extensive pathology in SIDS, potentially including abnormal neuron firing, synthesis, release, and clearance. The research suggested that the brains of SIDS babies contained an abnormal level of serotonin, though it was not clear whether it was more or less.

Medullary serotonergic neurons in the medulla oblongata project extensively to autonomic and respiratory nuclei in the brainstem and spinal cord and help regulate homeostatic function. Although the brainstem tissue from the SIDS infants contained more neurons, they appeared to contain fewer receptors for serotonin than did the brainstems of control infants. Male SIDS infants had fewer serotonin receptors than did either female SIDS infants or control infants, a finding that may provide preliminary neurochemical evidence explaining the increased vulnerability of boys to SIDS. The study was published in the November 1, 2006, issue of the Journal of the American Medical Association (JAMA).

"Our hypothesis right now is that we're seeing a compensation mechanism,” said co-author Dr. David Paterson, Ph.D. "If you have more serotonin neurons, it may be because you have less serotonin and more neurons are recruited to produce and use serotonin to correct this deficiency.”

Every year, about 2,000 seemingly healthy babies in the United States die of SIDS, or crib death. Studies have shown that infants who sleep on their stomachs are at higher risk of dying. The "Back to Sleep” campaign sponsored by the U.S. National Institutes of Health (NIH), which urges parents to place infants to sleep on their backs, has helped to reduce the number of deaths by 50% since 1994. Despite this, 65% of SIDS infants in the study were found to be sleeping on their stomachs or sides.



Related Links:
Children's Hospital Boston
Harvard Medical School

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.